Poly Medicure [POLYMED] vs Centennial Surgical [CSURGSU] Detailed Stock Comparison

Poly Medicure
NSE
Loading...

Centennial Surgical
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Poly Medicure wins in 11 metrics, Centennial Surgical wins in 7 metrics, with 0 ties. Poly Medicure appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Poly Medicure | Centennial Surgical | Better |
---|---|---|---|
P/E Ratio (TTM) | 56.51 | 2,482.50 | Poly Medicure |
Price-to-Book Ratio | 7.17 | 1.82 | Centennial Surgical |
Debt-to-Equity Ratio | 6.52 | 108.97 | Poly Medicure |
PEG Ratio | 250.96 | N/A | N/A |
EV/EBITDA | 41.50 | 16.07 | Centennial Surgical |
Profit Margin (TTM) | 20.28% | -2.74% | Poly Medicure |
Operating Margin (TTM) | 22.33% | 6.05% | Poly Medicure |
EBITDA Margin (TTM) | 22.33% | 6.05% | Poly Medicure |
Return on Equity | 15.99% | -4.65% | Poly Medicure |
Return on Assets (TTM) | 9.16% | 1.53% | Poly Medicure |
Free Cash Flow (TTM) | $-906.06M | $56.05M | Centennial Surgical |
Dividend Yield | 0.14% | N/A | N/A |
1-Year Return | 1.13% | 40.78% | Centennial Surgical |
Price-to-Sales Ratio (TTM) | 11.70 | 1.04 | Centennial Surgical |
Enterprise Value | $188.15B | $891.12M | Poly Medicure |
EV/Revenue Ratio | 11.27 | 1.67 | Centennial Surgical |
Gross Profit Margin (TTM) | 66.56% | 73.40% | Centennial Surgical |
Revenue per Share (TTM) | $168 | $147 | Poly Medicure |
Earnings per Share (Diluted) | $34.11 | $-4.01 | Poly Medicure |
Beta (Stock Volatility) | 0.04 | 0.49 | Poly Medicure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Poly Medicure vs Centennial Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Poly Medicure | 2.42% | -1.51% | -11.04% | -20.44% | -12.40% | -26.34% |
Centennial Surgical | 1.31% | 5.12% | -1.90% | 24.05% | 14.39% | 13.97% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Poly Medicure | 1.13% | 163.79% | 358.72% | 808.47% | 5,957.38% | 5,957.38% |
Centennial Surgical | 40.78% | 192.45% | 272.15% | 214.08% | 7,351.92% | 14,661.90% |
Performance & Financial Health Analysis: Poly Medicure vs Centennial Surgical
Metric | POLYMED | CSURGSU |
---|---|---|
Market Information | ||
Market Cap | ₹195.30B | ₹558.19M |
Market Cap Category | Mid cap | Small cap |
10 Day Avg. Volume | 143,078 | 134 |
90 Day Avg. Volume | 126,420 | 180 |
Last Close | ₹1,974.10 | ₹155.00 |
52 Week Range | ₹1,862.05 - ₹3,357.80 | ₹82.15 - ₹169.50 |
% from 52W High | -41.21% | -8.55% |
All-Time High | ₹3,357.80 (Oct 28, 2024) | ₹169.50 (Dec 16, 2024) |
% from All-Time High | -41.21% | -8.55% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.17% | 0.10% |
Quarterly Earnings Growth | 0.34% | 0.10% |
Financial Health | ||
Profit Margin (TTM) | 0.20% | -0.03% |
Operating Margin (TTM) | 0.22% | 0.06% |
Return on Equity (TTM) | 0.16% | -0.05% |
Debt to Equity (MRQ) | 6.52 | 108.97 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹268.63 | ₹84.30 |
Cash per Share (MRQ) | ₹117.33 | ₹0.60 |
Operating Cash Flow (TTM) | ₹2.40B | ₹170.74M |
Levered Free Cash Flow (TTM) | ₹-1,657,084,800 | ₹-42,696,752 |
Dividends | ||
Last 12-Month Dividend Yield | 0.14% | N/A |
Last 12-Month Dividend | ₹3.00 | N/A |
Valuation & Enterprise Metrics Analysis: Poly Medicure vs Centennial Surgical
Metric | POLYMED | CSURGSU |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 56.51 | 2,482.50 |
Forward P/E | 250.96 | N/A |
PEG Ratio | 250.96 | N/A |
Price to Sales (TTM) | 11.70 | 1.04 |
Price to Book (MRQ) | 7.17 | 1.82 |
Market Capitalization | ||
Market Capitalization | ₹195.30B | ₹558.19M |
Enterprise Value | ₹188.15B | ₹891.12M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 11.27 | 1.67 |
Enterprise to EBITDA | 41.50 | 16.07 |
Risk & Other Metrics | ||
Beta | 0.04 | 0.49 |
Book Value per Share (MRQ) | ₹268.63 | ₹84.30 |
Financial Statements Comparison: Poly Medicure vs Centennial Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | POLYMED | CSURGSU |
---|---|---|
Revenue/Sales | ₹4.41B | ₹133.08M |
Cost of Goods Sold | ₹1.47B | ₹35.40M |
Gross Profit | ₹2.93B | ₹97.68M |
Research & Development | ₹112.93M | N/A |
Operating Income (EBIT) | ₹984.32M | ₹8.05M |
EBITDA | ₹1.46B | ₹21.17M |
Pre-Tax Income | ₹1.23B | ₹-13.38M |
Income Tax | ₹310.15M | ₹-1.54M |
Net Income (Profit) | ₹918.34M | ₹-11.84M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | POLYMED | CSURGSU |
---|---|---|
Cash & Equivalents | ₹86.99M | ₹2.20M |
Total Current Assets | ₹19.17B | ₹629.64M |
Total Current Liabilities | ₹3.70B | ₹318.30M |
Long-Term Debt | ₹7.71M | N/A |
Total Shareholders Equity | ₹27.66B | ₹307.55M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹10.41B | ₹199.83M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | POLYMED | CSURGSU |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | POLYMED | CSURGSU |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 143,078 | 134 |
Average Daily Volume (90 Day) | 126,420 | 180 |
Shares Outstanding | 101.33M | 3.65M |
Float Shares | 33.77M | 615,942 |
% Held by Insiders | 0.67% | 0.81% |
% Held by Institutions | 0.19% | 0.00% |
Dividend Analysis & Yield Comparison: Poly Medicure vs Centennial Surgical
Metric | POLYMED | CSURGSU |
---|---|---|
Last 12-Month Dividend | ₹3.00 | N/A |
Last 12-Month Dividend Yield | 0.14% | N/A |
3-Year Avg Annual Dividend | ₹2.83 | N/A |
3-Year Avg Dividend Yield | 0.21% | N/A |
3-Year Total Dividends | ₹8.50 | N/A |
Ex-Dividend Date | Sep 19, 2024 | N/A |